MUMBAI Nov 8 India's Sun Pharmaceutical
Industries reported a 46.5 percent drop in quarterly
net profit after it set aside 5.84 billion rupees ($108.02
million) towards a possible compensation in a patent dispute
case related to drug Protonix.
The Mumbai-based drugmaker said consolidated net profit fell
to 3.2 billion rupees during fiscal second quarter ended
September from 5.98 billion rupees a year earlier. Net sales
rose 40.2 percent to 26.57 billion rupees.
Analysts had estimated the net profit at 7.68 billion
rupees, according to Thomson Reuters I/B/E/S.
($1 = 54.0650 Indian rupees)
(Reporting by Kaustubh Kulkarni; Editing by Jijo Jacob)